Innovative Research Award
Amr Ragaa
Egyptian Natural Gas Company – GASCO, Egypt
Amr Ragaa is a researcher affiliated with the Egyptian Natural Gas Company – GASCO whose indexed scholarly record encompasses 56 documents and 545 citations, with an h-index of 12. The publication portfolio supplied for this recognition profile demonstrates research activity spanning biomedical markers, genetic risk, molecular genetics, and computational biology, providing an interdisciplinary perspective relevant to contemporary scientific research and innovation.
Abstract
This academic recognition profile summarizes the documented research activity of Amr Ragaa in the context of the Innovative Research Award. The supplied bibliographic record indicates a sustained publication portfolio and measurable citation impact. Selected works address diabetic nephropathy biomarkers, rheumatoid arthritis genetics, vitamin D receptor polymorphisms, and computational investigation of parasite codon usage, illustrating methodological breadth across biomedical and computational research. [1] [2]
Keywords
- Biomedical research
- Molecular genetics
- Genetic polymorphism
- Computational biology
- Research innovation
Introduction
Research innovation increasingly depends on integrating experimental evidence, molecular characterization, genetic investigation, and computational approaches. Ragaa’s supplied publication record reflects this multidisciplinary orientation. The 2023–2024 works include studies published in journals such as International Journal of Diabetes in Developing Countries, Biochemical Genetics, and BMC Medical Genomics, alongside a computational research software contribution. [3]
Research Profile
The available metrics identify 56 documents, 545 citations, and an h-index of 12 in the supplied Scopus profile. These indicators provide a quantitative view of publication activity and scholarly visibility, while the selected publications offer qualitative evidence of work addressing clinically relevant biomarkers, disease susceptibility, genetic variation, and reproducible computational methods. [1]
Research Contributions
The documented studies contribute to several complementary areas. Research on microRNA-192, pentraxin-3, and transforming growth factor-beta1 examines their association with estimated glomerular filtration rate in adults with diabetic nephropathy. Another case-control study investigates genetic risk associated with rheumatoid arthritis. A further study evaluates biochemical markers alongside FokI and TaqI vitamin D receptor gene polymorphisms, while the parazitCUB package provides a computational resource for examining parasite codon usage bias. [2] [4]
Publications
- Association of microRNA-192, pentraxin-3, and transforming growth factor-beta1 with estimated glomerular filtration rate in adults with diabetic nephropathy. International Journal of Diabetes in Developing Countries, 2024. [1]
- Genetic Risk of Rheumatoid Arthritis: A Case Control Study. Biochemical Genetics, 2024. [2]
- parazitCUB: An R package to streamline the process of investigating the adaptations of parasites’ codon usage bias. F1000Research, 2023. [3]
- Biochemical markers and FokI and TaqI vitamin D receptor genes polymorphism in rheumatoid arthritis. BMC Medical Genomics, 2023. [4]
Research Impact
The supplied citation count of 545 and h-index of 12 indicate established scholarly visibility within the indexed research record. The diversity of subjects represented in the selected publications further suggests an ability to connect biomedical questions with genetic, molecular, and computational approaches. Impact should be interpreted alongside publication quality, collaboration, methodological rigor, and the independent use of findings by subsequent researchers. [1] [4]
Award Suitability
Based on the supplied bibliometric indicators and publication evidence, Amr Ragaa presents a research profile relevant to consideration for the Innovative Research Award. The combination of 56 documented publications, 545 citations, an h-index of 12, and interdisciplinary research topics provides a substantive basis for academic recognition. The final award assessment should additionally consider the complete scholarly record, originality, research leadership, reproducibility, and broader contribution to the relevant field.
Conclusion
Amr Ragaa’s documented research profile combines measurable scholarly impact with contributions across biomedical, genetic, molecular, and computational research. The selected publications demonstrate engagement with clinically relevant disease mechanisms and methodological development. Together with the supplied Scopus indicators, these records provide a structured academic basis for consideration within the Global Innovation Technologist Awards.
External Links
References
- Elsevier. (n.d.). Scopus author details: Amr Ragaa, Author ID 57196035854. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57196035854
- Springer Nature. (2024). Genetic Risk of Rheumatoid Arthritis: A Case Control Study. Biochemical Genetics.
DOI: https://doi.org/10.1007/S10528-023-10648-7
- F1000Research. (2023). parazitCUB: An R package to streamline the process of investigating the adaptations of parasites’ codon usage bias.
DOI: https://doi.org/10.12688/f1000research.143223.1
- Springer Nature. (2023). Biochemical markers and FokI and TaqI vitamin D receptor genes polymorphism in rheumatoid arthritis. BMC Medical Genomics.
DOI: https://doi.org/10.1186/S12920-023-01668-8
- Springer Nature. (2024). Association of microRNA-192, pentraxin-3, and transforming growth factor-beta1 with estimated glomerular filtration rate in adults with diabetic nephropathy. International Journal of Diabetes in Developing Countries. DOI: https://doi.org/10.1007/S13410-023-01283-4